2022 annual financial data
ABVC BioPharma 2022 Operating margin
Direct answer
Operating margin was -1,558.54%.
Operating income was -15,114,412 USD and net income was -16,423,239 USD.
Operating cash flow was -7,398,391 USD.
Get free ABVC BioPharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 969,783 USD
- Operating income
- -15,114,412 USD
- Net income
- -16,423,239 USD
- Operating cash flow
- -7,398,391 USD